牛牛AI助理已提取核心訊息
On December 31, 2023, Armistice Capital, LLC and its managing member Steven Boyd filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, reporting a change in their ownership stake in Bruush Oral Care Inc. The filing indicates that Armistice Capital, LLC and Steven Boyd collectively hold 821,965 shares of common stock in Bruush Oral Care Inc., which represents approximately 1.87% of the company's class of securities. This stake is managed by Armistice Capital, LLC on behalf of the Master Fund, which is the direct holder of the shares. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, indicating that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The total number of shares outstanding as of December 7, 2023, was reported to be 44,035,160. The filing was completed and signed by Steven Boyd on February 14, 2024.
On December 31, 2023, Armistice Capital, LLC and its managing member Steven Boyd filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, reporting a change in their ownership stake in Bruush Oral Care Inc. The filing indicates that Armistice Capital, LLC and Steven Boyd collectively hold 821,965 shares of common stock in Bruush Oral Care Inc., which represents approximately 1.87% of the company's class of securities. This stake is managed by Armistice Capital, LLC on behalf of the Master Fund, which is the direct holder of the shares. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, indicating that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The total number of shares outstanding as of December 7, 2023, was reported to be 44,035,160. The filing was completed and signed by Steven Boyd on February 14, 2024.
2023年12月31日,停戰資本有限責任公司及其管理成員史蒂芬·博伊德向美國證券交易委員會提交了經修訂的附表13G/A,報告了其在Bruush Oral Care Inc.的所有權發生變化。該文件顯示,停戰資本有限責任公司和史蒂芬·博伊德共持有Bruush Oral Care Inc. 的821,965股普通股,約佔該公司證券類別的1.87%。該股份由停戰資本有限責任公司代表萬事達基金管理,後者是股票的直接持有者。該文件是根據1934年《證券交易法》第13d-1(b)條提交的,表明股票是在正常業務過程中收購的,不是爲了改變或影響發行人的控制權。據報道,截至2023年12月7日,已發行股票總數爲44,035,160股。該文件由史蒂芬·博伊德於2024年2月14日完成並簽署。
2023年12月31日,停戰資本有限責任公司及其管理成員史蒂芬·博伊德向美國證券交易委員會提交了經修訂的附表13G/A,報告了其在Bruush Oral Care Inc.的所有權發生變化。該文件顯示,停戰資本有限責任公司和史蒂芬·博伊德共持有Bruush Oral Care Inc. 的821,965股普通股,約佔該公司證券類別的1.87%。該股份由停戰資本有限責任公司代表萬事達基金管理,後者是股票的直接持有者。該文件是根據1934年《證券交易法》第13d-1(b)條提交的,表明股票是在正常業務過程中收購的,不是爲了改變或影響發行人的控制權。據報道,截至2023年12月7日,已發行股票總數爲44,035,160股。該文件由史蒂芬·博伊德於2024年2月14日完成並簽署。
有用
沒用